Search
-
The End of the Beginning: The Evolving Landscape of Alzheimer’s Disease Pharmacotherapy
Read more about the recent breakthroughs, ongoing challenges, and future directions of Alzheimer’s disease pharmacotherapy.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
GLP-1s are more than just weight loss drugs. They're a chance to rewrite our evolutionary story, to take control of our biology in a way never before possible.
-
Does Everything Really Cause Cancer?
How our changing world is impacting our cells, and what it means for all of us.
-
Mid-Year Oncology Review 2025: History Informs the Future
What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.
-
Here's how synthetic data can accelerate product development
Revisit our on demand webinar exploring how cutting-edge technology is transforming product testing, delivering faster results, cost savings, and deeper consumer insights.
-
The Heart Truth: Understanding What We Don’t Know About Cardiac Health
New Ipsos survey conducted across six countries reveals that despite 84% claiming to be sufficiently informed on the cardiac health, only less than a half are.
-
The Power of Product Testing with Synthetic Data
Read more about generating and evaluating high-quality synthetic data and explore how synthetic data can be applied specifically to product testing.
-
Beyond Checkpoints: Next-Gen Therapeutics for Solid Tumors
Hear our expert panelists discuss the challenges and opportunities in the development of emerging therapeutic modalities aimed at addressing solid tumors in the post-PD1 era.
-
U.S. Biosimilars: Greater Access and New Commercial Models
Read more about the primary considerations that manufacturers – of both biosimilars and originator products – must factor into strategic plans going forward.
-
Ipsos and Haleon: thinking in the future tense
Learn how Ipsos and Haleon focused on having a futures mindset to identify global drivers of change while centering the human aspect of a changing world.